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Abstract 
Background: the effect of three drugs; Ketorolac, Paracetamol and Parecoxib, 
on patients undergoing lower extremities orthopedic surgeries were compared 
regarding their analgesic effects. 
Materials and methods: 140 patients undergoing lower extremities 
orthopedic surgery were assigned in four groups: 35 patients in each. In 
Parecoxib group, 20 mg of the drug was infused in 20 minutes and then 60 mg 
of Parecoxib was added to the pump and the rest of the pump was filled with 
normal saline up to100 ml. In Ketorolac group, 15 mg Ketorolac was infused 
in 20 minutes and then, 45 mg of Ketorolac was added into the pump and the 
rest of the pump was filled with normal saline up to 100 ml. In Paracetamol 
group 500 mg Paracetamol was infused in 20 minutes and then 1500 mg of 
Paracetamol was added into the pump and the rest of the pump was filled with 
normal saline up to 100 ml. In the placebo group, infusion pump was filled 
with 100 ml of normal saline. 
Results: Pain score was not significantly different between Paracetamol and 
placebo groups. Six hours after operation, only the difference in the mean 
pain scores between Parecoxib and placebo groups was significant. However, 
12 and 18 hours after operation, the mean pain score in Parecoxib group was 
significantly lower than Paracetamol and placebo groups (p<0.05). 
Nevertheless, 24 hours after operation, the mean pain score in Parecoxib and 
Ketorolac groups were significantly lower than placebo group (p<0.05).  
Conclusion: The results showed that Parecoxib could be used for postoperative 
pain management in orthopedic lower limb surgeries. Ketorolac and 
Paracetamol could reduce morphine requirements in similar patterns.  
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Introduction 
Postoperative pain particularly for orthopedic 
surgery is one of the physicians concerns since it 
causes patient dissatisfaction, bed dependency, and 
makes delay in ambulating. This may cause late 
hospital discharge, followed by additional costs for 
patients and the hospital (1). 
Postoperative pain causes physiologic and 
sometimes pathologic changes that include; high blood 
sugar levels in diabetics, electrolytes and fluid 
retention, tachycardia, hypertension, cardiac 
dysrhythmia, ischemia in susceptible patients, 
reduction of vital capacity, hypoventilation especially 
in abdominal and thorax surgery, 25-50% reduction in 
functional residual capacity (FRC), tachypnea, 
hypocapnia which leads to hypercapnia failure due to 
the patience’s fatigue, ileus that can lead to nausea and 
vomiting, food intolerance and delay in oral intake and 
inhibition of cellular and humoral immunity which can 
increase the risk of infection (2). 
Various methods are used to control pain, which 
include; use of various drugs (non-steroidal anti-
inflammatory drugs (NSAIDS) such as intramuscular 
Ketorolac, suppository Indomethacin, opioids), 
patient-controlled analgesia (PCA) with intramuscular, 
or intravenous analgesics injection, and different 
blocks such as lumbar or thoracic epidural block (3). 
Opioid is regarded as the initial postoperative pain 
therapy (4), and in recent years, their combination with 
other drugs such as nonsteroidal anti-inflammatory 
drugs are concerned (5). So that, patients receiving 
non-opioid drugs for postoperative pain control have 
experienced approximately 18% fewer side effects (6).  
In the hospital wards with minimal staff, 
tendency to use non-opioid analgesics has increased. 
Although some studies have been performed with 
NSAIDS intramuscular or bolus injections (7-9), but 
the comparison of drug infusion, especially in the 
aforementioned drugs, has not been reported. New 
non-opioid injectable drugs and lack of comparison of 
these three drugs together is the purpose of the study. 
Hence, comparing and evaluating them, effective drugs 
with fewer side effects can be recommended. This 
study aimed to compare the analgesic effect of 
intravenous infusion of Ketorolac, Paracetamol and 
Parecoxib for postoperative pain in orthopedic lower 
limb surgery under spinal anesthesia. 
Methods 
This study was a randomized double-blind 
clinical trial, comparing the control and treatment 
groups. The study was performed in Ayatollah Kashani 
(trauma center) and Al-Zahra Hospitals (Isfahan, Iran) 
on 140 patients undergoing elective orthopedic surgery 
of lower extremities who had inclusion criteria. The 
sample size was determined 35 patients in each group. 
The sample size was calculated using the sample size 
for compare the means, taking into account confidence 
level of 95% and test power of 80%, and the standard 
deviation of postoperative pain intensity according to 
the amount of postoperative pain intensity was 
estimated as 1.17. The minimum significant difference 
between the groups was considered as 0.8. 
Inclusion criteria was patients age of 18 to 60 
years’ old who underwent elective lower limb 
orthopedic surgery, using spinal anesthesia with 
general conditions in class I, II ASA, the patient 
consented to participate in the study. The exclusion 
criteria were steroid consumption, drug intake having 
interfere to prescribed drugs in the study in the last 24 
hours, under antidepressants, sleeping pills, or other 
interfering drugs, psychologically problems, drug 
abuse, renal disease, respiratory problems (asthma), 
liver disease, acute gastritis, high blood pressure, and 
uncontrolled coronary disease. On the conditions of 
developing severe dyspnea, gastrointestinal bleeding, 
respiratory symptoms requiring medical intervention, 
cardiac chest pain, change in the algorithm of 
prescribing analgesics for pain control and changing 
the anesthesia procedure, the patients were excluded. 
After sufficient justification of the purpose of 
study, from all patients oral and written consent was 
obtained. Patients were randomly placed into four 
groups of Placebo, Paracetamol, Parecoxib and 
Ketorolac. 
In the used random sampling method, the four 
first patients were assigned randomly to one of the 
groups, and subsequent patients were placed 
consecutively in the mentioned four groups according 
to the entrance order so that the sample size in each 
group reached 35 patients. In all four groups, infusion 
pump was connected with the speed of 4 ml per hour; 
all patients underwent spinal anesthesia with 3 ml of 
0.5% Marcaine for surgery. After surgery and after 
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regression of sensory block at two sensory 
dermatomes, the infusion pump was connected by the 
first personas following: In Parecoxib group, 20 mg 
was infused in 20 min and then 60 mg of Parecoxib was 
entered into the pump and the rest of the pump was 
filled with normal saline up to100 ml. In Ketorolac 
group, 15 mg Ketorolac was infused in 20 min and then 
45 mg of Ketorolac was entered into the pump and the 
rest of the pump was filled with normal saline up to 
100 ml. In Paracetamol group 500 mg Paracetamol was 
infused in 20 min and then 1500 mg of Paracetamol 
was entered into the pump and the rest of the pump was 
filled with normal saline up to 100 ml. In the placebo 
group, infusion pump was filled with 100 ml of normal 
saline. Then, the related questionnaire was filled by 
patients with the guidance of the second person (except 
first person who was aware of the content of the drug 
inside the pump). If the patient had visual analogue 
scale (VAS) more than 3, morphine 0.05 mg/kg IV was 
used. As necessary, this dose could have repeated after 
20 minutes. If the VAS was more than five initial doses 
was 0.1 mg/kg. Morphine dosage used, VAS, VRS, 
and the side effects were recorded in the questionnaire. 
The sedation levels were noted in Ramsay sedation 
scale basis. For vomiting, 10 mg intravenous 
metoclopramide was used. In resistance cases 
intravenous ondansetron 4 mg was used and if 
vomiting was continued, for more evaluation and 
treatments patient excluded from study. After data 
collection, SPSS 12 analyzed the data. Statistical tests 
used for data analysis included Chi-Square test, one-
way ANOVA, and ANOVA analysis with repeated 
observations. 
 
Ramsay Sedation Scale:  
 anxious and agitated or restless, or both 
(anxious) 
 co-operative, oriented, and tranquil (conscious); 
responds to commands only (respond to order) 
 exhibits rapid response to light glabellar tap or 
loud auditory stimulus (rapid response) 
 exhibits a sluggish response to light glabellar tap 
or loud auditory stimulus (delay Response) 
 exhibits no response (no response) 
Results 
Among 201 studied patients, 53 ones were not 
eligible; eight patients refused informed consent and 
 
Figure 1. Patients who entered to the study, divided into the study groups and analyzed. 
201 patient reviewed
140 Patients randomly divided 
35 patient assigned 
to Parecoxib group
24 hour follow -up 
Completed : 32 Patients
Excluded : 3 Patients
32 patients 
were analyzed
35 patient assigned 
to Ketrolac group
24 hour follow-up




35 patients assigned 
to paracetamol group





35 patients assigned 
to Placebo group






53 : not eligible
8: Refused concent
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did not enter to the study. Finally, 140 eligible patients 
were randomly assigned into intervention groups; then 
they were followed for 24 hours. During follow-up 
period, eight patients were excluded; eight patients due 
to side effects or other causes, and two patients did not 
desire to continue. One patient due to chest pain 
(ketorolac group) , four patient due to severe vomiting 
(a patient from Parecoxib group, a patient from 
Paracetamol group, 2 patients from placebo group) one 
patient from paracetamol group had hidden addiction , 
and two patient discharge earlier than 24 hour (a 
patient Parecoxib and a patient placebo). Finally, 32 
patients in Parecoxib group, 34 patients in Ketorolac 
group, 32 patients in Paracetamol group and 32 
patients in placebo group completed the study; in such 
a way that their data were analyzed (Table 1). 
The mean age of the studied patients was 
35.7±11.6 years. Seventy-seven (58.3%) were male 
and 55 (41.7%) were female. Table 1 shows patient’s 
demographic and operative data. No significant 
differences were noted between intervention groups for 
mean of age, sex combination, weight, duration of 
surgery, and gastric pain (p≥0.5). The frequency of 
postoperative nausea and vomiting in Paracetamol and 
placebo groups was more than Parecoxib and 
Ketorolac groups but was not significantly different 
(P≥0.5).  
Pain score measured by VAS among groups was 
compared at time points and results are shown in table 
2. At baseline, the mean of pain score was not 
significantly different among groups (p>0.05). 
Between Paracetamol and placebo groups pain score 
was not significantly different at any time point. In 
Ketorolac group, pain score in hours 6, 12 and 18 was 
similar to placebo. At hour 6, only the difference in the 
mean of pain between Parecoxib and placebo groups 
was statistically significant. At hours 12 and 18, the 
mean of pain score in Parecoxib group was 
significantly lower than Paracetamol and placebo 
groups. At hours 24, the mean of pain score in 
Parecoxib and Ketorolac groups was significantly 
lower than placebo group (Figure 1). 
Figure 2 shows the frequency of pain intensity 
measured by VRS among groups at time points. 
Accordingly, there was no significant difference 
among groups at baseline. At hours 6, 18.8% of 
patients in placebo group reported “severe pain” 
whereas in other groups “severe pain” was not reported 
(p=0.003). In addition, the frequency of pain intensity 
at hours 12 and 18 was significantly different among 
groups; “painless” was more frequent in Parecoxib 
group compare to other groups. At hours 24, painless 
was more frequent in Parecoxib group compare to 
other groups but the difference in frequency of pain 
levels among groups was not statistically significant. 
Based on the results, the frequency of conscious 
Table 1: Patients demographic and operative data 
 
P-value 
Study groups  




*0.99 35.4 11.1 35.9 12.2 36.2 11.3 35.3 12.1 Age (year) 
*0.98 71.2 13.3 71.1 13.3 70.3 13.2 70.4 13.5 Body weight (kg) 
0.46# 19.13 16.18 22.12 20.12 Sex (male/female) 
*0.71 80.2 9.1 80.6 10 81.5 8 79 9.3 Duration of surgery 
(min) 
0.12# 11(34.4) 13(38.2) 7(20.6) 5(15.6) Postoperative nausea 
0.22# 6(18.8) 6(17.6) 2(5.9) 2(6.2) Postoperative vomiting 
0.08# 0 2(5.9) 5(14.7) 1(3.3) Gastric pain 
Data expressed as mean   SD or number (percent) 
P-values calculated by * one-way ANOVA and # Chi-square 
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(grade two Ramsay sedation scale) at hours 6, 12 and 
24, was more than other levels and in hour 18, the 
frequency of “rapid response” (grade four Ramsay 
sedation scale) was more than other levels. The hour 
18 in most cases was at mid night and later. Totally, the 
frequency of sedation levels among groups at time 
points was similar and no significant differences were 
noted among groups (p>0.05). Figure 3 shows the 
results in comparison of the frequency of sedation 
levels among groups at time points. 
 
The overall Morphine request mean in placebo 
group was significantly more than other groups. The 
mean of Morphine consumption in placebo group was 
26.3 mg whereas in Parecoxib, Ketorolac and 
Paracetamol groups were 8.9, 11.9 and 14.7 mg, 
respectively. In addition, the difference between 
Parecoxib and Paracetamol groups was statistically 
significant. However, the differences between 
Ketorolac group with Parecoxib group or Paracetamol 
group was not statistically significant (Figure 4). 
Discussion 
One of the most important factors for early 
hospital discharge and mobilization of patient is 
adequacy of postoperative analgesia (10). Using of 
non-opioid analgesics in patients after surgery is 
important in reducing postoperative pain and opioid 
requirements. In this study, we investigated the 
influence of Parecoxib, Ketorolac and Paracetamol on 
postoperative pain and opioid consumption in patients 
underwent orthopedic surgery under spinal anesthesia. 
Our findings indicate that in compare to placebo, the 
intravenous infusion of Parecoxib significantly reduces 
pain in the first 24 hours after the surgery but decrease 
of pain intensity after administration of Ketorolac or 
Paracetamol was not significantly more than placebo.  
 
Figure 2. Comparison of pain level by verbal rating scale of among study groups at time point. The difference in pain was 
statistically significant among groups at hour 6, 12 and 18 (P <0.05). 
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The comparison between Parecoxib and 
Ketorolac in some had different findings. Two studies 
compared the efficacy of intravenous 30 mg of 
ketorolac and intravenous 40 mg of Parecoxib at 
induction. First study by Ng et al, showed that in the 
first hour after laparoscopic sterilization Parecoxib at 
induction of anesthesia was less effective than 
Ketorolac (11). Other study by Siribumrungwong et al, 
reported that postoperative pain reduction in both the 
Ketorolac and Parecoxib was significantly better than 
 
Figure 3. Comparison of the frequency of sedation level among study groups at time points. The difference in sedation 
levels was not statistically significant among groups at time points (P > 0.05). Equivalency to Ramsay sedation scale: 
anxious = 1, conscious= 2, respond to order =3, rapid response=4). 
 
Figure 4. Morphine consumption (mg per 24 h) after Parecoxib, Ketorolac, Paracetamol, or placebo for postoperative 
analgesia. *P-values <0.05. 
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the placebo group but the pain scores of between 
Ketorolac and Parecoxib at any time points were not 
different (3). Our study showed that Ketorolac and 
Parecoxib was better than placebo and in contrast to 
these two studies in our study Parecoxib was more 
effective than Ketorolac in the first 24 hours after 
surgery for pain management. The differences between 
these findings might be explained by the difference in 
surgeries and the pharmacokinetics of Parecoxib and 
Ketorolac. Duration of surgeries in Ng A, et al, study 
(11) was shorter than our study, in our study was 
shorter than Siribumrungwong et al, study were (3). 
In some randomized trial, Paracetamol was 
evaluated in compare to Parecoxib. In Gehling et al, 
study 8 and 24 h after surgery Parecoxib provides 
superior analgesia compared with placebo or 
Paracetamol (12). Gupta et al, in a randomized trial 
have evaluated the efficacy of postoperative 
intravenous Paracetamol and Parecoxib undergoing 
elective surgery and reported that pain score was 
significantly less in Parecoxib group at rest compared 
to Paracetamol group (13). Although, surgeries 
procedures were different but similar to other studies, 
our findings show the better effect of Parecoxib 
compare to Paracetamol in postoperative pain 
alleviation. 
In a meta-analysis of randomized trials (14), the 
effect of perioperative single dose of Ketorolac to 
prevent postoperative pain was assessed and their 
findings showed that, overall, 24 hours’ pain score did 
not significantly reduce compared with placebo like 
the present study. However, they reported that some 
trials showed that neither 30 nor 60 mg of Ketorolac is 
associated with a statistically significant reduction of 
24 hours’ pain, which was dissimilar to our study. The 
differences between our findings and other study can 
explain by different techniques whereas we used 
postoperative intravenous infusion of 60 mg ketorolac 
but other noted studies used pre-operative or intra-
operative single dose of Ketorolac.  
The other results of the present study proved 
that Parecoxib, Ketorolac or Paracetamol significantly 
reduce total morphine requirements during 24 hours 
after surgery. Parecoxib was reduce total Morphine 
requirements compare to Ketorolac or Paracetamol but 
was significantly more effective than Paracetamol. 
Similar to our results, several randomized controlled 
trials after Parecoxib use for patients after thyroid 
surgery, total hip or knee arthroplasty, hysterectomy 
and laparoscopic cholecystectomy reported a 
significant reduction in postoperative opioid 
consumption (12, 14, 15). In addition, similarly, 
Oliveira et al. in their meta-analysis showed that, 
overall, ketorolac significantly reduced postoperative 
opioid consumption compared with placebo (14). In 
contrast to our results, Siribumrungwong et al., did not 
found significant difference between Parecoxib, 
Ketorolac and placebo for total morphine requirements 
during 24 hours after surgery. Dissimilarity between 
our findings and Siribumrungwong et al. (3) findings 
in total morphine requirements can be explain by the 
different in time of injection and duration of surgery, 
whereas in Siribumrungwong et al. study drugs were 
injected around 30 minutes prior to incision and 
duration of surgery in this study was longer than our 
study. 
Conclusion 
We compared the clinical efficacy among 
Parecoxib, Ketorolac and Paracetamol for 
postoperative pain management. We found that the 
pain score and the total dose of morphine requirement 
in the Parecoxib treatment group were lower than that 
in Ketorolac, Paracetamol and placebo groups. 
Therefore, our study revealed that Parecoxib in 
conjunction with opioids can be used for postoperative 
pain management and Morphine requirement can be 
reduced same as Ketorolac as and more than 
Paracetamol. 
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